+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
MAITREYA

Maitreya Medicare Share Price

 

 

Maitreya Medicare live price: ₹155.6. It opened at ₹154 vs previous close ₹155; intraday high/low: ₹165/₹154. The 50 & 200 DMA stand at ₹178.25/₹215.81.

Maitreya Medicare Performance

  • Today's Low
  • ₹154
  • Today's High
  • ₹165
  • 52 Week Low
  • ₹153
  • 52 Week High
  • ₹299
  • Open Price₹154
  • Previous Close₹155
  • Volume4,400
  • 50 DMA₹178.25
  • 100 DMA₹193.67
  • 200 DMA₹215.81

Maitreya Medicare Chart

Investment Returns

  • Over 1 Month -17.67%
  • Over 3 Month -18.53%
  • Over 6 Month -38.66%
  • Over 1 Year -41.56%

Smart Investing Starts Here Start SIP with Maitreya Medicare for Steady Growth!

Invest Now

Maitreya Medicare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -42.8
  • PEG Ratio
  • -
  • Market Cap Cr
  • 105
  • P/B Ratio
  • 4
  • Average True Range
  • 10.02
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • -3.68
  • RSI
  • 34.4
  • MFI
  • 20.98

Latest Stock News Updates

Maitreya Medicare IPO: Check GMP, subscription status on day 1, other key details

Maitreya Medicare IPO opens on October 27 and closes on November 1. Maitreya Medicare IPO price band set at 78-82. Maitreya Medicare IPO raises 4.05 crore from anchor investors.

Maitreya Medicare IPO opens tomorrow, price band set at 78-82 apiece. Check GMP, other details

Maitreya Medicare IPO opens Oct 27, closes Nov 1, price band 78-82. Maitreya Medicare IPO raised 4.05 crore from anchor investors Maitreya Medicare IPO worth 14.89 crore, no offer for sale component.

Maitreya Medicare Financials

Maitreya Medicare Technicals

EMA & SMA

Current Price
₹155.60
+ 0.9 (0.58%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹168.91
  • 50 Day
  • ₹178.25
  • 100 Day
  • ₹193.67
  • 200 Day
  • ₹215.81

Resistance and Support

156.72 Pivot Speed
  • R3 166.88
  • R2 164.17
  • R1 159.43
  • S1 151.98
  • S2 149.27
  • S3 144.53

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Maitreya Medicare Ltd has an operating revenue of Rs. 91.51 Cr. on a trailing 12-month basis. An annual revenue de-growth of -3% needs improvement, Pre-tax margin of -5% needs improvement, ROE of -8% is poor and needs improvement. The company has a debt to equity of 76%, which is bit higher. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 5 which is a POOR score indicating inconsistency in earnings, a RS Rating of 6 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 68 indicates it belongs to a poor industry group of Medical-Hospitals and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Maitreya Medicare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-29 Audited Results
2026-03-10 Others To consider and approve Employee Stock Option Scheme.
2025-11-14 Quarterly Results
2025-05-30 Audited Results
2024-10-28 Quarterly Results

Maitreya Medicare Shareholding Pattern

73.11%
0%
21.64%
5.25%

Maitreya Medicare FAQs

Maitreya Medicare share price is ₹155 As on 05 June, 2026 | 10:47

The Market Cap of Maitreya Medicare is ₹105.4 Cr As on 05 June, 2026 | 10:47

The P/E ratio of Maitreya Medicare is -42.8 As on 05 June, 2026 | 10:47

The PB ratio of Maitreya Medicare is 4 As on 05 June, 2026 | 10:47

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23